Author:
Zainuddin Mohd,Vinod A. B.,Gurav Sandip Dhondiram,Police Anitha,Kumar Avinash,Mithra Chandan,Dewang Purushottam,Kethiri Raghava Reddy,Mullangi Ramesh
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference14 articles.
1. Auchus RJ (2004) Overview of dehydroepiandrosterone biosynthesis. Semin Reprod Med 22:281–288
2. Debes JD, Tindall DJ (2004) Mechanisms of androgen-refractory prostate cancer. N Engl J Med 351:1488–1490
3. Dreicer R, Agus DB, MacVicar GR, MacLean T, Zhang W, Stadler M (2010) Safety, pharmacokinetics, and efficacy of TAK-700 in castration-resistant metastatic prostate cancer: a phase I/II open label study. In: ASCO Genitourinary Cancer Symposium Proceedings, June 3–7, Chicago, IL, USA, Abstract 103
4. Gurav S, Police A, Zainuddin M et al (2012) Development and validation of a highly sensitive LC-MS/MS-ESI method for determination of Orteronel® (TAK-700) in rat plasma: application to a pharmacokinetic study. Bioanalysis 4:1471–1480
5. Hellerstedt BA, Pienta KJ (2002) The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 52:154–179
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献